lncRNAs combine and crosstalk with NSPc1 in ATRA‑induced differentiation of U87 glioma cells

  • Authors:
    • Zhikong Liang
    • Yuliang Wang
    • Hui Li
    • Yi Sun
    • Yanhua Gong
  • View Affiliations

  • Published online on: April 15, 2019     https://doi.org/10.3892/ol.2019.10254
  • Pages: 5821-5829
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Nervous system polycomb 1 (NSPc1) is a member of the polycomb group (PcG) family of proteins and has been demonstrated to maintain the differentiation and pluripotency of stem cells. Long non‑coding RNAs (lncRNAs) have been demonstrated to be involved in the control of pluripotency and differentiation in embryonic and pluripotent cells. In the present study, the expression levels of NSPc1 were associated with the malignant potential of various glioma cell lines. Additionally, lncRNAs were differentially expressed in glioblastoma cell lines. Following induced differentiation of U87 glioblastoma cells with all‑trans retinoic acid, the expression levels of NSPc1 decreased initially, reaching its lowest point on day 6, but then subsequently increased until day 10. The expression of lncRNA candidates decreased in the cell differentiation stage. Additionally, the expression of metastasis‑associated lung adenocarcinoma transcript 1 (MALAT1), sex‑determining region of the Y chromosome‑box 2 overlapping transcript (SOX2OT) and antisense non‑coding RNA in the INK4 locus (ANRIL) was significantly altered relative to the expression levels of NSPc1. RNA immunoprecipitation (RIP) assays demonstrated that MALAT1, SOX2OT and ANRIL bind to NSPc1 in U87 glioblastoma cells and the enrichment of ANRIL in anti‑NSPc1 antibody group was associated with the expression levels of NSPc1 during U87 cell differentiation. Small interfering RNA mediated downregulation of NSPc1 expression with MALAT1, SOX2OT and ANRIL, inhibited the proliferation, and promoted apoptosis in U87 cells. The results of the present study demonstrate that MALAT1, SOX2OT and ANRIL combine and crosstalk with NSPc1 in U87 cells to affect proliferation and apoptosis.

References

1 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Sathornsumetee S, Rich JN and Reardon DA: Diagnosis and treatment of high-grade astrocytoma. Neurol Clin. 251111–1139. (x)2007. View Article : Google Scholar : PubMed/NCBI

3 

Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, et al: Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol. 10:79–87. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT and Alvarez RD: Gene therapy and ovarian cancer: A review. Obstet Gynecol. 89:145–155. 1997. View Article : Google Scholar : PubMed/NCBI

5 

Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH and Roberts CW: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 18:316–328. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Su Y, Deng B and Xi R: Polycomb group genes in stem cell self-renewal: A double-edged sword. Epigenetics. 6:16–19. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Morey L and Helin K: Polycomb group protein-mediated repression of transcription. Trends Biochem Sci. 35:323–332. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Sauvageau M and Sauvageau G: Polycomb group proteins: Multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 7:299–313. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Prezioso C and Orlando V: Polycomb proteins in mammalian cell differentiation and plasticity. FEBS Lett. 585:2067–2077. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Pasini D, Bracken AP and Helin K: Polycomb group proteins in cell cycle progression and cancer. Cell Cycle. 3:396–400. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Jacobs JJ and van Lohuizen M: Polycomb repression: From cellular memory to cellular proliferation and cancer. Biochim Biophys Acta. 1602:151–161. 2002.PubMed/NCBI

12 

Chang CJ and Hung MC: The role of EZH2 in tumour progression. Br J Cancer. 106:243–247. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Nunes M, Blanc I, Maes J, Fellous M, Robert B and McElreavey K: NSPc1, a novel mammalian Polycomb gene, is expressed in neural crest-derived structures of the peripheral nervous system. Mech Dev. 102:219–222. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Li H, Fan R, Sun M, Jiang T and Gong Y: Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19 embryonal carcinoma cells via directly activating Oct4. Biochem Biophys Res Commun. 440:527–532. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Pritsker M, Ford NR, Jenq HT and Lemischka IR: Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci USA. 103:6946–6951. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Yan Y, Zhao W, Huang Y, Tong H, Xia Y, Jiang Q and Qin J: Loss of polycomb group protein Pcgf1 severely compromises proper differentiation of embryonic stem cells. Sci Rep. 7:462762017. View Article : Google Scholar : PubMed/NCBI

17 

Gong Y, Yue J, Wu X, Wang X, Wen J, Lu L, Peng X, Qiang B and Yuan J: NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element. Nucleic Acids Res. 34:6158–6169. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Hu PS, Xia QS, Wu F, Li DK, Qi YJ, Hu Y, Wei ZZ, Li SS, Tian NY, Wei QF, et al: NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma. Oncogene. 36:4706–4718. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Huang Y, Liu N, Wang JP, Wang YQ, Yu XL, Wang ZB, Cheng XC and Zou Q: Regulatory long non-coding RNA and its functions. J Physiol Biochem. 68:611–618. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Wilusz JE: Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. Biochim Biophys Acta. 1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Tsai MC, Spitale RC and Chang HY: Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Lu Q, Ren S, Lu M, Zhang Y, Zhu D, Zhang X and Li T: Computational prediction of associations between long non-coding RNAs and proteins. BMC Genomics. 14:6512013. View Article : Google Scholar : PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Wu X, Gong Y, Yue J, Qiang B, Yuan J and Peng X: Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res. 36:3590–3599. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Xiang J, Guo S, Jiang S, Xu Y, Li J, Li L and Xiang J: Silencing of long non-coding RNA MALAT1 promotes apoptosis of glioma cells. J Korean Med Sci. 31:688–694. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Zhang D, Ding L, Li Y, Ren J, Shi G, Wang Y, Zhao S, Ni Y and Hou Y: Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Sci Rep. 7:162312017. View Article : Google Scholar : PubMed/NCBI

31 

Rolle K: miRNA multiplayers in glioma. From bench to bedside. Acta Biochim Pol. 62:353–365. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Caley DP, Pink RC, Trujillano D and Carter DR: Long noncoding RNAs, chromatin, and development. ScientificWorldJournal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Ling GQ, Liu YJ, Ke YQ, Chen L, Jiang XD, Jiang CL and Ye W: All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation. Mol Med Rep. 12:165–172. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Jiao F, Hu H, Han T, Yuan C and Wang L, Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci. 16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, Xu TP, Xia R, Yang JS, De W and Chen JF: Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liang, Z., Wang, Y., Li, H., Sun, Y., & Gong, Y. (2019). lncRNAs combine and crosstalk with NSPc1 in ATRA‑induced differentiation of U87 glioma cells. Oncology Letters, 17, 5821-5829. https://doi.org/10.3892/ol.2019.10254
MLA
Liang, Z., Wang, Y., Li, H., Sun, Y., Gong, Y."lncRNAs combine and crosstalk with NSPc1 in ATRA‑induced differentiation of U87 glioma cells". Oncology Letters 17.6 (2019): 5821-5829.
Chicago
Liang, Z., Wang, Y., Li, H., Sun, Y., Gong, Y."lncRNAs combine and crosstalk with NSPc1 in ATRA‑induced differentiation of U87 glioma cells". Oncology Letters 17, no. 6 (2019): 5821-5829. https://doi.org/10.3892/ol.2019.10254